Brevan Howard Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,619
Closed -$39.7K 2078
2026
Q1
$39.7K Buy
+11,619
New +$39.2K ﹤0.01% 2101
2025
Q4
Sell
-55,400
Closed -$386K 1777
2025
Q3
$386K Buy
+55,400
New +$391K ﹤0.01% 1424
2024
Q3
Sell
-18,665
Closed -$445K 1131
2024
Q2
$445K Buy
+18,665
New +$438K ﹤0.01% 651

Other funds holding ASPN

Brevan Howard Capital Management's ASPN Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 11,619 shares — an estimated $39.7K sold.

Brevan Howard Capital Management first reported a position in ASPN in Q2 2024 and held it in 3 quarters. The position peaked at $445K in Q2 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 11,619 Aspen Aerogels shares in Q2 2026, an estimated $39.7K.
  • Brevan Howard Capital Management first reported a position in Aspen Aerogels in Q2 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Aspen Aerogels position peaked at $445K in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.